Brief: Island Pharmaceuticals Seeks Trading Halt
01/03/2026 22:47
March 2 (Reuters) - Island Pharmaceuticals Ltd ILA.AX: SEEKS TRADING HALT PENDING AGREEMENT WITH US BIODEFENCE INSTITUTIONS Further company coverage: ILA.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says FDA Grants Orphan Designation For Galidesivir In Marburg
Australia's Island Pharmaceuticals rises on agreement extension with US Army
Brief: Island Pharmaceuticals Says GMP Manufacturing Of Galidesivir Commenced
Australia's Island Pharmaceuticals rises on US government collaboration
Brief: Island Pharmaceuticals Seeks Trading Halt